CTIS2023-510173-34-00进行中（未招募）1 期
A long-term follow-up study for patients treated with Galapagos CAR T-cell therapies - LTF-CL-001
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- Galapagos
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •Subject must be able and willing to comply with the clinical study protocol (CSP) requirements and must sign and date the informed consent form (ICF) as approved by the Independent Ethics Committee (IEC) / Institutional Review Board (IRB), prior to any study-related procedures., All subjects who have been treated with a GLPG CAR T-cell therapy in a clinical trial or Managed Access Program.
排除标准
- •There are no exclusion criteria for this study.
研究者
相似试验
进行中（未招募）
1 期
A Follow-Up Study of Long-Term Efficacy of Patients with HER2-Positive Early Breast Cancer Who Had Been Enrolled in Study CT-P6 3.2ong-term safety and efficacy of treatment with CT-P6 (Herzuma) in HER-2 positive early breast cancer patientsEUCTR2019-003518-15-ROCelltrion, Inc.216
进行中（未招募）
1 期
A Follow-Up Study of Long-Term Efficacy of Patients with HER2-Positive Early Breast Cancer Who Had Been Enrolled in Study CT-P6 4.2ong-term safety and efficacy of treatment with CT-P6 (Herzuma) in HER-2 positive early breast cancer patientsEUCTR2019-003518-15-PLCelltrion, Inc.350
进行中（未招募）
不适用
A Long-term Continuation Study of Patients With Infantile-Onset Pompe Disease WhoWere Previously Enrolled in Protocol AGLU01602Pompe disease or glycogenosis type IIMedDRA version: 6.1Level: HLTClassification code 10024579EUCTR2005-001629-27-ITGENZYME
进行中（未招募）
不适用
A Long-term Continuation Study of Patients with Infantile-Onset Pompe Disease who were previously enrolled in Protocol AGLU01602Pompe disease is a rare metabolic muscle disease inherited in an autosomal recessive fashion. Pompe disease is caused by a deficiency of GAA, which is needed for the degradation of lysosomal glycogen. Pompe disease is characterized by organelle bound (lysosomal) accumulation of glycogen in many body tissues. In general, there is an inverse correlation between the amount of residual GAA activity in patients with Pompe disease and the severity of the disease.EUCTR2005-001629-27-DEGenzyme Europe BV17
进行中（未招募）
不适用
Evaluation of the effects of chronic treatment with venlafaxine (150 mg) and pregabalin (200 mg) on emotional indices of anxiety and panic induced by breathing carbon dioxide.Generalised anxiety disorderMedDRA version: 9.1Level: LLTClassification code 10018075Term: Generalised anxiety disorderEUCTR2008-000971-15-GBniversity of Bristol54